Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis

BACKGROUND: Liraglutide is glucagon-like peptide-1 receptor agonist for treating patients with type 2 diabetes mellitus. Our previous studies have demonstrated that liraglutide protects cardiac function through improving endothelial function in patients with acute myocardial infarction undergoing pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Shun-Ying, Zhang, Ying, Zhu, Ping-Jun, Zhou, Hao, Chen, Yun-Dai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329734/
https://www.ncbi.nlm.nih.gov/pubmed/28270843
http://dx.doi.org/10.11909/j.issn.1671-5411.2017.01.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329734/
https://www.ncbi.nlm.nih.gov/pubmed/28270843
http://dx.doi.org/10.11909/j.issn.1671-5411.2017.01.008

Ejemplares similares